Author:
Chen L,Zhao Y,Halliday G C,Berry P,Rousseau R F,Middleton S A,Nichols G L,Del Bello F,Piergentili A,Newell D R,Lunec J,Tweddle D A
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Ambrosini G, Sambol EB, Carvajal D, Vassilev LT, Singer S, Schwartz GK (2007) Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1. Oncogene 26 (24): 3473–3481.
2. Bakos E, Evers R, Szakacs G, Tusnady GE, Welker E, Szabo K, de Haas M, van Deemter L, Borst P, Varadi A, Sarkadi B (1998) Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J Biol Chem 273 (48): 32167–32175.
3. Benard J, Bourhis J, de Vathaire F, Ferrandis E, Terrier-Lacombe MJ, Lemerle J, Riou G, Hartmann O (1994) Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis. Prog Clin Biol Res 385: 111–116.
4. Breier A, Gibalova L, Seres M, Barancik M, Sulova Z (2013) New insight into p-glycoprotein as a drug target. Anticancer Agents Med Chem 13 (1): 159–170.
5. Carr-Wilkinson J, O'Toole K, Wood KM, Challen CC, Baker AG, Board JR, Evans L, Cole M, Cheung NK, Boos J, Kohler G, Leuschner I, Pearson AD, Lunec J, Tweddle DA (2010) High frequency of p53/MDM2/p14ARF pathway abnormalities in relapsed neuroblastoma. Clin Cancer Res 16 (4): 1108–1118.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献